Abstract
During a 2-year period, the vancomycin-resistant enterococcus (VRE) acquisition rate was 10.9% (40/368) in patients who had shared a room with a newly detected VRE carrier. Exposure to vancomycin and to anti-anaerobic antibiotics were identified as independent risk factors for VRE acquisition. Sensitivity of the first rectal VRE screening was less than 50%.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Bacterial Agents / therapeutic use
-
Carrier State*
-
Cross Infection / prevention & control*
-
Disease Transmission, Infectious / prevention & control*
-
Gram-Positive Bacterial Infections / transmission*
-
Humans
-
Infection Control
-
Ontario
-
Rectum / microbiology
-
Risk Factors
-
Tertiary Care Centers
-
Vancomycin-Resistant Enterococci / isolation & purification*